Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
Wave Life Sciences Ltd. announced Q1 2026 financial results showing improved net loss compared to prior year and significant cash reserves to fund operations through Q3 2028. The company reported key clinical progress including FDA acceptance to initiate the Phase 2a trial of WVE-007 for obesity, upcoming data presentations from the AATD-targeted W…